montbretins (University of British Columbia)

N/A

Report date: 2025/03/20 14:55:25
NME

Base Information

Drug Namemontbretins (University of British Columbia)
Drug Alias Namemontbretin-A (University of British Columbia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSalivary alpha-amylase inhibitors
TargetsSalivary alpha-amylase
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A